Abilify MyCite

Digital Pharmacist

The RxWiki Digital Pharmacist stamp of approval lets you know that this content has been created and reviewed by a licensed pharmacist.

Abilify MyCite treats adults with schizophrenia, bipolar I disorder, or depression. Each tablet contains an Ingestible Event Marker (IEM) sensor meant to track the medication.

Abilify MyCite Overview

Reviewed: November 21, 2017
Updated: 

Abilify MyCite is a prescription medication used in the treatment of such conditions as schizophrenia and bipolar disorder. It can also be used in combination with an antidepressant to treat depression. Abilify MyCite belongs to a group of drugs called atypical antipsychotics. These medications work by altering the activity of certain natural substances in the brain.

Abilify MyCite contains a sensor to detect whether the medication is being taken. The Abilify MyCite system also comes with a MyCite Patch, a wearable patch, that detects the sensor after Abilify MyCite has been taken. The MyCite Patch will send data to the MyCite App and a portal where a healthcare provider and caregiver can see the information.

This medication comes in tablet form and is usually taken once a day, with or without food.

Do not chew, divide, or break Abilify MyCite tablets. Swallow tablets whole.

Common side effects of Abilify MyCite include an inner sense of restlessness or need to move and insomnia. Abilify MyCite can also cause drowsiness or dizziness. Do not drive or operate heavy machinery until you know how Abilify MyCite affects you.

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other
  • Schizophrenia
  • Schizophrenia And Disorders With Psychotic Features

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Abilify MyCite Drug Class

Back to Top

Abilify MyCite is part of the drug class:

Abilify MyCite FDA Warning

Back to Top

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS

  • Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. ABILIFY MYCITE is not approved for the treatment of patients with dementia-related psychosis.  
  • Increased risk of suicidal thoughts and behaviors in pediatric and young adult patients taking antidepressants. Closely monitor for worsening and emergence of suicidal thoughts and behaviors.
  • The safety and effectiveness of ABILIFY MYCITE have not been established in pediatric patients.